Skip to content

Cannabis: all studies

Page 193 of 295: studies 1,921 to 1,930 of 2,943, newest first. Back to the cannabis overview

Research

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Journal of Psychoactive Drugs February 20, 2025 Broc A. Pagni, Andreas Halman, Jerome Sarris et al. 7 citations

The durability of ayahuasca's effects on mental health and the influence of clinical diagnoses on therapeutic response is unclear. Adults with no prior exposure to ayahuasca (n = 66) participating in neo-shamanic ayahuasca ceremonies completed questionnaires at baseline, 7 days, and 1, 6, and 12 months. Mixed models were used to characterize temporal trajectories in mental health, alcohol and...

Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.

Frontiers in Public Health 2025 Jakub Sobieraj, Jakub Sleziak, Michał Szyszka et al.

Mental health disorders such as depression are a rising issue among university students. Some of them use complementary and alternative medicine (CAM) as self-administered therapy instead of or together with professional care. Defining the scale of the problem, its underlying reasons and possible implications are crucial for addressing it in clinical psychiatry and public health strategies. A...

Modern perspectives on psychoses: dissociation, automatism, and temporality across exogenous and endogenous dimensions.

Frontiers in Psychiatry 2025 Valerio Ricci, Maria Celeste Ciavarella, Carlotta Marrangone et al. 7 citations

Substance use and the emergence of Novel Psychoactive Substances (NPS) present a significant public health challenge and diagnostic dilemma, particularly in the context of psychosis. The increasing availability of psychoactive substances among youth has led to a rise in Substance Use Disorders (SUDs), with profound implications for mental health. This paper explores the psychopathological...

DOI: 10.3389/fpsyt.2025.1543673 (opens in new tab) Full text (opens in new tab) Cannabis Dissociation Exogenous psychosis Mental automatism +3

PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.

Frontiers in Psychiatry 2025 Julia Marek, Magdalena Domek-Gumprecht, Agata Macionga et al.

PolDrugs is a biennial epidemiological study aimed at analyzing patterns of mostly illicit psychoactive substance use in Poland in the context of psychiatry and harm reduction. This survey was held for the third time, and its results were compared to the last two editions. The survey was conducted as an online survey with 37 closed-ended single-choice questions and 3 multiple-choice questions....

Exploring the Impact of Recreational Drugs on Suicidal Behavior: A Narrative Review

Psychoactives July 3, 2024 Rosa María Moret, Sergio Sanz‐gómez, Santiago Gascón et al. 4 citations

Substance use/abuse and suicide are two closely related phenomena, mostly due to neurobiological, psychological, and social impairments. In the present narrative review, the relationship between suicidal behavior (SB) and the use and abuse of common recreational drugs, such as alcohol, cannabis, cocaine, methamphetamine, heroin, nicotine, ketamine, psilocybin, MDMA, and LSD, has been explored....

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 8, 2024 Jenny L Wiley, Julie A. Marusich, Bruce E. Blough et al.

The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9-Tetrahydrocannabinol (Δ9-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used...

Adolescent Psychedelic Use and Psychotic or Manic Symptoms

JAMA Psychiatry March 13, 2024 Otto Simonsson, Miriam A. Mosing, Walter Osika et al. 41 citations

Importance While psychedelic-assisted therapy has shown promise in the treatment of certain psychiatric disorders, little is known about the potential risk of psychotic or manic symptoms following naturalistic psychedelic use, especially among adolescents. Objective To investigate associations between naturalistic psychedelic use and self-reported psychotic or manic symptoms in adolescents...

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Brain Sciences March 3, 2024 Mario Renato Velit-Salazar, Eloise Cherian, Paulo R Shiroma 13 citations

Objective: This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among healthy individuals and patients with post-traumatic stress disorder (PTSD) or major depressive disorder (MDD). Methods: The Preferred Reporting Items for Systematic Reviews (PRISMA) was used as a guide to structure and report the findings for this review. A...

Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.

Cannabis and Cannabinoid Research February 1, 2024 Faiz M Kassim, Sophie Tod, Jennifer Rodger et al.

Background: Memory impairments and psychosis-like experiences can be adverse effects of cannabis use. However, reports on the cognitive impact of cannabis use are not consistent. There are also limited studies on the psychotomimetic effects of cannabinoid compounds to reveal the association between cannabis and psychosis. Therefore, we investigated the effect of acute cannabinoid intoxication...

Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022

Addiction January 11, 2024 Nicolas Garel, Steven Tate, Kristin Nash et al. 23 citations

Abstract Background and aims Hallucinogens encompass a diverse range of compounds of increasing scientific and public interest. Risks associated with hallucinogen use are under‐researched and poorly understood. We aimed to compare the trends in hallucinogen‐associated health‐care use with alcohol‐ and cannabis‐associated health‐care use. Design, setting and cases We conducted an ecological...

DOI: 10.1111/add.16432 (opens in new tab) Cannabis Hallucinogen Emergency department Environmental health